help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goossens, G. H.
Right arrow Articles by van Baak, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goossens, G. H.
Right arrow Articles by van Baak, M. A.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 6 2690-2696
Copyright © 2004 by The Endocrine Society


Obesity: Original Article

Angiotensin II-Induced Effects on Adipose and Skeletal Muscle Tissue Blood Flow and Lipolysis in Normal-Weight and Obese Subjects

G. H. Goossens, E. E. Blaak, W. H. M. Saris and M. A. van Baak

Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, 6200 MD Maastricht, The Netherlands

Address all correspondence and requests for reprints to: G. H. Goossens, Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. E-mail: g.goossens{at}hb.unimaas.nl.

The present study was designed to investigate the effects of angiotensin II (Ang II) on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects using the microdialysis technique. Microdialysis probes were placed in the abdominal sc adipose tissue left and right from the umbilicus and in the gastrocnemius muscle of both legs in eight normal-weight and eight obese men. Probes were consecutively perfused with 1.0 nM Ang II, 1.0 µM Ang II, and 1.0 µM Ang II + 48 µM hydralazine or with Ringer solution (control). Ethanol and glycerol concentrations in the dialysate were measured as an indicator of local blood flow and lipolysis, respectively. Ang II caused an increase in ethanol outflow/inflow ratio, compared with baseline values both in adipose tissue (average of both groups, Ang 1.0 nM: 0.03 ± 0.01, P = 0.02; Ang 1.0 µM: 0.05 ± 0.01, P < 0.01) and muscle (average of both groups, Ang 1.0 nM: 0.02 ± 0.01, P = 0.09; Ang 1.0 µM: 0.04 ± 0.01, P = 0.01), indicating a decrease in local blood flow. These effects were not significantly different in obese and normal-weight subjects. The decrease in local blood flow was accompanied by unchanged interstitial glycerol concentrations in adipose tissue (except during the supraphysiological dose) and skeletal muscle, suggesting that Ang II inhibits lipolysis in both tissues. Thus, the present data suggest that Ang II decreases local blood flow in a dose-dependent manner and inhibits lipolysis both in adipose and skeletal muscle tissue. These effects were not significantly different in obese and normal-weight subjects in both tissues.

Abbreviations: Ang II, Angiotensin II; ANP, atrial natriuretic peptide; RAS, renin-angiotensin system.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Rao, Z. H. Huang, and T. Mazzone
Angiotensin II Regulates Adipocyte Apolipoprotein E Expression
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4366 - 4372.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. H. Goossens, J. W.E. Jocken, E. E. Blaak, P. M. Schiffers, W. H.M. Saris, and M. A. van Baak
Endocrine Role of the Renin-Angiotensin System in Human Adipose Tissue and Muscle: Effect of {beta}-Adrenergic Stimulation
Hypertension, March 1, 2007; 49(3): 542 - 547.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. H. Goossens, S. E. McQuaid, A. L. Dennis, M. A. van Baak, E. E. Blaak, K. N. Frayn, W. H. M. Saris, and F. Karpe
Angiotensin II: a major regulator of subcutaneous adipose tissue blood flow in humans
J. Physiol., March 1, 2006; 571(2): 451 - 460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Boschmann, S. Engeli, F. Adams, G. Franke, F. C. Luft, A. M. Sharma, and J. Jordan
Influences of AT1 receptor blockade on tissue metabolism in obese men
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R219 - R223.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. D. Robertson, A. S. T. Bickerton, A. L. Dennis, H. Vidal, D. P. Jewell, and K. N. Frayn
Enhanced Metabolic Cycling in Subjects after Colonic Resection for Ulcerative Colitis
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2747 - 2754.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Cabassi, P. Coghi, P. Govoni, E. Barouhiel, E. Speroni, S. Cavazzini, A. M. Cantoni, R. Scandroglio, and E. Fiaccadori
Sympathetic Modulation by Carvedilol and Losartan Reduces Angiotensin II-Mediated Lipolysis in Subcutaneous and Visceral Fat
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2888 - 2897.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society